Search Results - "Westermann F"

This result is not displayed to guests.
Login for full access.

Neuroblastoma: biology and molecular and chromosomal pathology.

Authors: Schwab M Westermann F Hero B et al.

Source: Lancet Oncology. Aug2003, Vol. 4 Issue 8, p472-480. 9p.

This result is not displayed to guests.
Login for full access.

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.

Authors: Althoff, K Beckers, A Bell, E et al.

Source: Oncogene. 6/25/2015, Vol. 34 Issue 26, p3357-3368. 12p. 6 Color Photographs, 1 Chart, 1 Graph.

RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance.

Authors: Salm, F Cwiek, P Ghosal, A et al.

Source: Oncogene. 8/22/2013, Vol. 32 Issue 34, p3944-3953. 10p. 1 Black and White Photograph, 8 Graphs.

Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma.

Authors: Fiaschetti, G Castelletti, D Zoller, S et al.

Source: Oncogene. 6/23/2011, Vol. 30 Issue 25, p2823-2835. 13p.

MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.

Authors: Afanasyeva, E. A. Mestdagh, P. Kumps, C. et al.

Source: Cell Death & Differentiation. Jun2011, Vol. 18 Issue 6, p974-984. 11p. 1 Black and White Photograph, 1 Diagram, 1 Chart, 5 Graphs.

Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients.

Authors: Oberthuer, A. Juraeva, D. Li, L. et al.

Source: Pharmacogenomics Journal. Aug2010, Vol. 10 Issue 4, p258-266. 9p. 1 Diagram, 1 Chart, 3 Graphs.

MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.

Authors: Mestdagh, P. Fredlund, E. Pattyn, F. et al.

Source: Oncogene. 3/4/2010, Vol. 29 Issue 9, p1394-1404. 11p. 1 Diagram, 1 Chart, 4 Graphs.

Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.

Authors: Fischer, M. Bauer, T. Oberthür, A. et al.

Source: Oncogene. 2/11/2010, Vol. 29 Issue 6, p865-875. 11p. 2 Diagrams, 1 Chart, 3 Graphs.

Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.

Authors: Nowacki, S. Skowron, M. Oberthuer, A. et al.

Source: Oncogene. 5/22/2008, Vol. 27 Issue 23, p3329-3338. 10p. 1 Black and White Photograph, 1 Diagram, 3 Graphs.

126 - Flubendazole as potential anti-neuroblastoma therapy option.

Authors: Michaelis, M. Agha, B. Rothweiler, F. et al.

Source: European Journal of Cancer. Dec2016 Supplement 1, Vol. 69, pS47-S47. 1p.

553 - Flubendazole as potential anti-neuroblastoma therapy option.

Authors: Michaelis, M. Agha, B. Florian, R. et al.

Source: European Journal of Cancer. Jul2016 Supplement 1, Vol. 61, pS120-S120. 1p.

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Authors: Federico A Gopisetty A Surdez D et al.

Source: Cancer research [Cancer Res] 2026 Jul 10. Date of Electronic Publication: 2026 Jul 10.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.

Authors: Herter S Emperador M Smyrilli K et al.

Source: Cell death & disease [Cell Death Dis] 2025 Aug 25; Vol. 16 (1), pp. 644. Date of Electronic Publication: 2025 Aug 25.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

NIK-driven IL-23 production by myeloid cells is a key factor in the development of autoimmune inflammation.

Authors: Ramphal NS Liu X Palagi I et al.

Source: The Journal of experimental medicine [J Exp Med] 2026 Apr 06; Vol. 223 (4). Date of Electronic Publication: 2026 Feb 27.

Publication Type: Journal Article

Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Authors: Werr L Boland J Petersen J et al.

Source: The Journal of clinical investigation [J Clin Invest] 2026 Feb 12; Vol. 136 (7). Date of Electronic Publication: 2026 Feb 12 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

GM-CSF-mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus.

Authors: Mills KAM Westermann F Espinosa V et al.

Source: Science immunology [Sci Immunol] 2025 Mar 21; Vol. 10 (105), pp. eadr0547. Date of Electronic Publication: 2025 Mar 21.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Telomere content and genomics of myeloid neoplasia by whole-genome sequencing.

Authors: Guarnera L Wahida A Gurnari C et al.

Source: Blood [Blood] 2026 Jan 08; Vol. 147 (2), pp. 197-208.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Authors: Saint-Charles A Masliah-Planchon J Saberi-Ansari E et al.

Source: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2026 Jan; Vol. 28 (1), pp. 27-38. Date of Electronic Publication: 2025 Oct 17.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE